First, Aravinda Chakravarti drew a map of how scientists might unravel the genetics of complex disease. Then he blazed the trail.
First, Aravinda Chakravarti drew a map of how scientists might unravel the genetics of complex disease. Then he blazed the trail.
The microbiome of the lung is different in patients with the disease, which causes a thick buildup of mucus that makes breathing difficult.
After a lightning-fast approval, the first medicine to treat an underlying cause of the disorder hits the market.
Scientists track changes in bacterial genomes during a hospital outbreak to discover potential pathogenesis genes.
Page 1 of 1